ARDS is often associated with the release of inflammatory mediators (e.g., IL6 and TNF-α) [31]; reactive oxidative species [31] that may disrupt endothelial and vascular integrity, causing capillary leakage; decreased microvascular flow; and compromised vascular regulation, leading to tissue hypoperfusion. This evidence concerns the gene TNF and acute respiratory distress syndrome.